Fresh analysis reveals that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds much more quickly than those who end traditional diet and exercise plans.
Findings released in a major medical journal shows that while overweight individuals often shed substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Individuals using these medications need to be cognizant of the risk of rapid weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.
Such speed of regain implies a reversion to starting mass within about 18 months.
Weighing Therapies
The study, which looked at dozens of trials involving thousands of patients, compared the effects of GLP-1 agonists with other pills.
The team note that individuals who lose weight through diet and exercise typically see a less rapid creep back—around 0.1 kg a month—after stopping.
Explaining the Rapid Regain
Doctors believe the way of the drugs explains the amplified regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication leads to appetite is unsuppressed, making excessive eating much more probable."
A Lifelong Issue?
Medical guidelines suggest the injections for people with obesity-related health risks, accompanied by recommended lifestyle changes.
A number of clinicians contend that, given the significant potential of relapse, the treatment might need to be life-long.
This perspective is reinforced by drug manufacturers, who note that the results "highlight the persistent character of excess weight," comparing it to managing conditions like hypertension.
User Experiences
People who have come off the jabs describe a powerful resurgence of cravings.
"It was like a trigger that goes on and I was suddenly starving," said one woman.
This difficulty is worsened if users have not developed permanent dietary or behavioural modifications during therapy.
Widespread Adoption
Recent estimates suggest that a significant number of people in the UK have used these injections in the past year, with desire continuing to grow.
- Adoption is greater among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
Ultimately, experts caution that while the jabs are powerful agents for weight loss, they are not a magic fix and maintained weight loss hinges on combined lifestyle management.
